We will dramatically improve the management of allergy and autoimmune diseases, by providing healthcare professionals with superior diagnostic technologies and clinical expertise for early diagnosis, better predictive utility and improved patient care.

 

We will make ImmunoCAPâ and EliAä testing an everyday practice in medicine to create a world where all patients are properly diagnosed for allergy and autoimmunity in time for appropriate treatment.